2018
DOI: 10.1101/433128
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Selective sweep and phylogenetic models for the emergence and spread of pyrimethamine resistance mutations inPlasmodium vivax

Abstract: Pyrimethamine resistance is a major concern for the control of human haemoprotozoa, especially Plasmodium species. Currently, there is little understanding of how pyrimethamine resistance developed in Plasmodium vivax in the natural field conditions. Here, we present first time the evidence of positive selection pressure on a dihydrofolate reductase locus and its consequences on the emergence and the spread of pyrimethamine resistance in P. vivax in the Punjab province of Pakistan. First, we examined the pyrim… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
4
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(6 citation statements)
references
References 36 publications
(49 reference statements)
2
4
0
Order By: Relevance
“…Overall, buparvaquone resistance-associated SNPs were reported for the first time in buffalo-and cattle-derived T. annulata field isolates and their impact on positive selection pressure. Our results are consistent with the study of the pyrimethamine resistance mutations in the protozoan parasite Plasmodium vivax (Auliff et al, 2006;Brega et al, 2004;de Pecoulas et al, 1998;Hastings et al, 2005;Imwong et al, 2003;Kaur et al, 2006;Kuesap et al, 2011;Lu et al, 2012;Mint Lekweiry et al, 2012;Ranjitkar et al, 2011;Schunk et al, 2006;Shaukat et al, 2019) and diminazene resistance in the Trypanosoma brucei (Carter et al, 1999;Mäser et al, 1999;Matovu et al, 2001). A possible explanation for the differences in the frequency of buparvaquone-conferring mutations with positive selection pressure may be variable drug doses, for example, if the 262S (TCA), 253S (TCT) and 129G (GGC)/253S (TCT) resistance mutations may be selected at low doses of buparvaquone, while 129G (GGC) may occur at higher doses.…”
Section: Discussionsupporting
confidence: 92%
See 4 more Smart Citations
“…Overall, buparvaquone resistance-associated SNPs were reported for the first time in buffalo-and cattle-derived T. annulata field isolates and their impact on positive selection pressure. Our results are consistent with the study of the pyrimethamine resistance mutations in the protozoan parasite Plasmodium vivax (Auliff et al, 2006;Brega et al, 2004;de Pecoulas et al, 1998;Hastings et al, 2005;Imwong et al, 2003;Kaur et al, 2006;Kuesap et al, 2011;Lu et al, 2012;Mint Lekweiry et al, 2012;Ranjitkar et al, 2011;Schunk et al, 2006;Shaukat et al, 2019) and diminazene resistance in the Trypanosoma brucei (Carter et al, 1999;Mäser et al, 1999;Matovu et al, 2001). A possible explanation for the differences in the frequency of buparvaquone-conferring mutations with positive selection pressure may be variable drug doses, for example, if the 262S (TCA), 253S (TCT) and 129G (GGC)/253S (TCT) resistance mutations may be selected at low doses of buparvaquone, while 129G (GGC) may occur at higher doses.…”
Section: Discussionsupporting
confidence: 92%
“…The selective sweep on these individual isolates was effectively softer and a genetic footprint of selection was also detected by significant departures from the neutrality test. The results are consistent with the hypothesis that single and multiple mutations in dhfr locus emerged in the human protozoan parasite P. vivax (Shaukat et al, 2019). Overall, the data provide novel information on single and or multiple emergences of resistance mutations in this group of parasites that may have implications for targeted selective treatment, or use of different drug combinations, including new drugs or the modification of current compounds in resistance mitigation strategies.…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations